¼¼°èÀÇ ¼ÒÈ­¼º ±Ë¾ç °Ë»ç ½ÃÀå
Peptic Ulcer Testing
»óǰÄÚµå : 1513979
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,372,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,117,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼ÒÈ­¼º ±Ë¾ç °Ë»ç ¼¼°è ½ÃÀåÀº 2030³â±îÁö 7¾ï 8,900¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 5¾ï 4,280¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼ÒÈ­¼º ±Ë¾ç °Ë»ç ¼¼°è ½ÃÀåÀº 2023-2030³â°£ CAGR 5.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7¾ï 8,900¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½ÇÇè½Ç Å×½ºÆ®´Â CAGR 6.0%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 4¾ï 1,060¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. »óºÎ ³»½Ã°æ °Ë»ç ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 4,440¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼ÒÈ­¼º ±Ë¾ç °Ë»ç ½ÃÀåÀº 2023³â 1¾ï 4,440¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1¾ï2,420¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023-2030³âÀÇ CAGRÀº 5.1%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 5.0%¿Í 4.5%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ±â¼úÀÇ Áøº¸, ´ç´¢º´ À¯º´·ü Áõ°¡, Àû±ØÀûÀÎ °Ç°­ °ü¸®ÀÇ Á߿伺 Áõ°¡¿¡ ÈûÀÔ¾î ±Þ¼ÓÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ´ç´¢º´ ÀÌȯÀ²Àº ºñ¸¸, °í·ÉÈ­, ½Ä»ýȰÀÇ È¥¶õ°ú ¿îµ¿ ºÎÁ· µî »ýȰ ½À°ü µîÀÇ ¿äÀο¡ ÀÇÇØ »ó½ÂÇϰí ÀÖÀ¸¸ç, È¿°úÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Áö¼Ó Ç÷´ç ¸ð´ÏÅÍ(CGM)´Â Å©°Ô ÁøÈ­ÇÏ°í ¿ø·¡ÀÇ Àν¶¸° Ä¡·á¸¦ Áö¿øÇÏ´Â °Íº¸´Ù ³ôÀº Á¤È®¼º°ú °£Æí¼ºÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀåÀÇ Áö¼ÓÀûÀÎ È®´ë´Â ±â¼ú ¹ßÀü, °Ç°­ °ü¸® ÅëÇÕ, ¼¼°è ´ç´¢º´ ºÎ´ã Áõ°¡¿¡ ´Þ·Á ÀÖ½À´Ï´Ù. ºñħ½ÀÀû ±â¼ú, AI ÅëÇÕ, ¿þ¾î·¯ºí µð¹ÙÀ̽º µîÀÇ Çõ½ÅÀÌ ¹Ì·¡ÀÇ Àü¸ÁÀ» Çü¼ºÇϰí ÀÖÀ¸¸ç, ´ç´¢º´ °ü¸®¿Í ȯÀÚ ÄɾîÀÇ °­È­°¡ ±â´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÌ º¸´Ù »ç¿ëÇϱ⠽¬¿öÁü¿¡ µû¶ó ¼¼°è ´ç´¢º´ °ü¸®°¡ Å©°Ô °³¼±µÉ °ÍÀ¸·Î ±â´ëµÇ¸ç, ƯÈ÷ ½ÅÈï±¹¿¡¼­ °Ç°­ °ü¸® ÀÎÇÁ¶ó°¡ °­È­µÊ¿¡ µû¶ó Á¦Á¶¾÷ü´Â ÃæºÐÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú µ¿Çâ¿¡´Â Æ÷µµ´ç ¼öÁØ¿¡ ´ëÇÑ ½Ç½Ã°£ ÅëÂû·ÂÀ» Á¦°øÇÏ´Â CGM ½Ã½ºÅÛ°ú °°Àº ±â¼úÀû µµ¾à°ú Æ÷µµ´ç ¸ð´ÏÅ͸µ¿¡ AI ÅëÇÕÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ½Ã°£ÀÌ Áö³²¿¡ µû¶ó µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ÇâÈÄ Æ÷µµ´ç °ªÀÇ µ¿ÇâÀ» ¿¹ÃøÇÏ¿© ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¼±Á¦ °ü¸®ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀΰøÁö´É(AI)Àº ´ç´¢º´ °ü¸®¸¦ Æ÷ÇÔÇÑ °Ç°­ °ü¸®ÀÇ ¿©·¯ Ãø¸éÀ» À籸¼ºÇÕ´Ï´Ù. ´õ ³ªÀº ½ºÅ©¸®´×°ú ¸ð´ÏÅ͸µÀ» ÃËÁøÇÏ´Â Á¤ºÎ Á¤Ã¥Àº Àڱ⠸ð´ÏÅ͸µÀ» °­Á¶Çϴ ȯÀÚ ±³À°°ú ÇÔ²² ä¿ëÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÏ»ó »ýȰ°ú ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â ¿þ¾î·¯ºí Æ÷µµ´ç ¸ð´ÏÅͰ¡ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â Æ÷µµ´ç ¼öÁØÀ» Áö¼ÓÀûÀ¸·Î ÃßÀûÇÏ°í ¸ÅÀÏ ¿©·¯ ¹ø ¼Õ°¡¶ôÀ» Âñ·¯ °Ë»ç¸¦ ¼öÇà ÇÒ Çʿ䰡 ¾ø´Â ÆíÀǼºÀ» Á¦°øÇÕ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñÀÇ 41»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Peptic Ulcer Testing Market to Reach US$789.0 Million by 2030

The global market for Peptic Ulcer Testing estimated at US$542.8 Million in the year 2023, is expected to reach US$789.0 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$410.6 Million by the end of the analysis period. Growth in the Upper Endoscopy segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$144.4 Million While China is Forecast to Grow at 5.1% CAGR

The Peptic Ulcer Testing market in the U.S. is estimated at US$144.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$124.2 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Glucose Monitoring Devices Market - Key Trends and Drivers Summarized

The market for glucose monitoring devices is experiencing rapid growth, fueled by technological advancements, increasing diabetes prevalence, and a rising emphasis on proactive health management. Global diabetes rates are climbing due to factors such as obesity, aging populations, and lifestyle habits such as poor diet and inactivity, amplifying the need for effective monitoring solutions. Continuous Glucose Monitors (CGMs) have evolved significantly, offering high accuracy and simplicity beyond their original insulin therapy support.

Continued market expansion hinges on technological progress, healthcare integration, and the escalating diabetes burden worldwide. Innovations like non-invasive technologies, AI integration, and wearable devices are shaping the future landscape, promising enhanced diabetes management and patient care. As these solutions become more accessible, they're expected to significantly improve global diabetes management, especially as healthcare infrastructure strengthens in emerging economies, presenting ample growth opportunities for manufacturers.

Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices. These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.

Select Competitors (Total 41 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â